Novel strategies targeting detrimental airway inflammation
11 – 20 of 24
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
8-Oxoguanine targeted by 8-oxoguanine DNA glycosylase 1 (OGG1) is central to fibrogenic gene activation upon lung injury
- Contribution to journal › Article
-
Mark
High prevalence of interstitial lung abnormalities in middle-aged never-smokers
- Contribution to journal › Article
-
Mark
Substrate-specific binding of 8-oxoguanine DNA glycosylase 1 (OGG1) reprograms mucosal adaptations to chronic airway injury
- Contribution to journal › Scientific review
-
Mark
Epigenetic control of type III interferon expression by 8-oxoguanine and its reader 8-oxoguanine DNA glycosylase1
- Contribution to journal › Article
- 2022
-
Mark
Hereditary angioedema is associated with an increased risk of venous thromboembolism
- Contribution to journal › Letter
-
Mark
The effect of the COVID-19 pandemic on severe asthma care in Europe: Will care change for good?
- Contribution to journal › Article
-
Mark
Pharmacological OGG1 inhibition decreases murine allergic airway inflammation
- Contribution to journal › Article
-
Mark
Zoledronic Acid Targeting of the Mevalonate Pathway Causes Reduced Cell Recruitment and Attenuates Pulmonary Fibrosis
- Contribution to journal › Article
-
Mark
Innate Immune Responses to RSV Infection Facilitated by OGG1, an Enzyme Repairing Oxidatively Modified DNA Base Lesions
- Contribution to journal › Article
-
Mark
Experimental Model of Pulmonary Inflammation Induced by SARS-CoV-2 Spike Protein and Endotoxin
- Contribution to journal › Article
